Irisin and osteonectin emerged as the useful biomarkers to predict sarcopenia indexes in COPD and CHF patients, while the other biomarkers showed varying degrees of correlations with sarcopenia indexes (Table 2). The gene discussed is SPARC; the disease is chronic obstructive pulmonary disease.